Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DDI Study of Itraconazole and Cyclosporine on Lotiglipron PK
NCT05745701Phase 1Completed
- Sponsor
- Pfizer
- Start
- Feb 2023
- Primary completion
- May 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of lotiglipron in obesity and Overweight, sponsored by Pfizer. Primary endpoint: Area Under the Curve From Time Zero to Extrapolated Infinite Time. Started Feb 2023; status: completed.
02
Drugs
lotiglipron
03
Conditions
obesityOverweight
Beyond the preview
Go deeper on NCT05745701.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05745701.